Improving translational studies: lessons from rare neuromuscular diseases

Area of Science:

• Translational medicine
• Rare disease research
• Animal modeling

Background:

• Rare diseases affect fewer than 1 in 2000 people, with over 7000 identified, often lacking effective treatments.
• Pharmaceutical companies are prioritizing rare disease therapy development, with many being single-gene disorders.
• The laboratory mouse is a key model due to its manipulable genome, essential for studying these genetic conditions.

Discussion:

• Evaluating the utility of mouse models in translational medicine is critical for rare disease drug development.
• Current challenges in translational research necessitate improved methodologies and guidelines.
• Focusing on neuromuscular rare diseases, this editorial explores best practices to enhance the translational potential of animal studies.

Key Insights:

• Mouse models offer significant potential for rare disease research, particularly for single-gene disorders.
• Improving the translational validity of animal studies is essential for successful human therapy development.
• Established guidelines and good laboratory practices can enhance the predictive power of mouse models.

Outlook:

• The strategies discussed for neuromuscular rare diseases may serve as a model for other rare disease fields.
• Enhanced translational research in animal models can accelerate the development of effective rare disease treatments.
• Continued refinement of animal models and research practices will be vital for future therapeutic breakthroughs.